Endo, BioDelivery painkiller effective in late-stage study
July 7 (Reuters) - Endo International Plc and BioDelivery Sciences International Inc said their experimental pain drug was found effective in a late-stage trial.
The painkiller, BEMA buprenorphine, was being tested against a placebo in patients with pain severe enough to require around-the-clock, long-term opioid treatment.
Opioids are a class of drugs that includes not only powerful prescription painkillers like morphine, oxycodone and fentanyl but also heroin. (Reporting by Natalie Grover in Bangalore; Editing by Saumyadeb Chakrabarty)